Healthcare -
Biotechnology - NASDAQ - US
$ 1.54
0 %
$ 4.63 M
Market Cap
-0.14
P/E
SONN - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities SONN - Sonnet BioTherapeutics Holdings, Inc.
6.49 M
LAST VALUE
27.19%
2 YEAR CAGR
23.55%
5 YEAR CAGR
7.92%
10 YEAR CAGR